Clinical Trials Directory

Trials / Completed

CompletedNCT04274348

Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum

Role of Staphylococci on Cytokine and T Cell Profiles in the Pathogenesis of Atopic Dermatitis and Eczema Herpeticum

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease. Clinical studies have demonstrated a link between staphylococcal skin colonization and the pathogenesis of AD, but the implication of bacterial virulence factors remains largely uncharacterized. Finally, AD is often associated with herpes simplex skin infections. The aim of this project is to investigate the role of staphylococcal toxins in the exacerbation and maintenance of atopic skin inflammation and in the occurrence of infectious complications such as eczema herpeticum.

Conditions

Interventions

TypeNameDescription
OTHERSkin biopsies and blood samplesTwo skin biopsies and 30 ml of blood will be collected.

Timeline

Start date
2020-10-15
Primary completion
2025-08-04
Completion
2025-08-04
First posted
2020-02-18
Last updated
2025-12-29

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04274348. Inclusion in this directory is not an endorsement.